...
首页> 外文期刊>Nanomedicine >Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer
【24h】

Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer

机译:抗CD47单链可变片段的发展靶向磁性纳米粒子以治疗人膀胱癌

获取原文
获取原文并翻译 | 示例

摘要

Aim: To develop a novel anti-CD47 single-chain variable fragment (scFv) functionalized magnetic nanoparticles (MNPs) for targeting bladder cell lines and its applicability in thermotherapy. Material & methods: An immunized murine antibody phage display library was constructed and screened to isolate anti-CD47 binders. A scFv was selected and conjugated to MNPs which was then utilized to discriminate CD47(+) bladder cells along with assessing its efficacy in thermotherapy. Results: An scFv with high affinity to bladder cells was efficiently conjugated to MNPs. Following a hyperthermia treatment, the function of scFv-MNP conjugates led to a considerable reduction in cell viability. Conclusion: The anti-CD47 scFv-MNP conjugate was an effective cancer cell thermotherapy tool that might pave the way for development of bionano-based targeting techniques in both early detection and treatment of cancer.
机译:目的:开发一种用于靶向膀胱细胞系的新型抗CD47单链可变片段(SCFV)官能化磁性纳米粒子(MNP)及其在热处理中的适用性。 材料和方法:构建并筛选免疫鼠抗体噬菌体展示文库以分离抗CD47粘合剂。 选择SCFV并与MNP缀合,然后用于区分CD47(+)膀胱细胞以及评估其在热处理中的功效。 结果:高亲和力对膀胱细胞的SCFV有效地与MNP缀合。 在热疗治疗后,SCFV-MNP缀合物的功能导致细胞活力相当大降低。 结论:抗CD47 SCFV-MNP缀合物是一种有效的癌细胞热疗工具,可以为癌症的早期检测和治疗均来铺平基于均沙诺的靶向技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号